Phar­ma­cist warns of ‘silent killer’

Southern Telegraph - - OPINION -

A Rock­ing­ham phar­ma­cist has warned of a largely undiagnosed “silent killer”, with eight out of 10 peo­ple not real­is­ing they have the con­di­tion.

Sleep ap­noea is a dis­or­der char­ac­terised by short­ness of breath or pauses in breath­ing while a per­son is asleep, with snor­ing a side ef­fect of the con­di­tion.

Obe­sity and di­a­betes are linked to sleep ap­noea.

“What hap­pens is your body ac­tu­ally stops breath­ing overnight — it puts an in­cred­i­ble amount of pressure on your heart,” Phar­macy 777’s Sam Af­sar said. “A patient with un­treated sleep ap­noea, not only are they tired, fa­tigued and at a higher risk of workplace ac­ci­dents, they’re at a sig­nif­i­cantly in­creased risk of heart at­tacks and strokes.”

Mr Af­sar said anyone with con­cerns about en­ergy lev­els, fa­tigue or who had di­a­betes could have sleep ap­noea. Phar­macy 777 part­ners with res­pi­ra­tory and sleep physi­cian Dr Sina Ka­hani to un­der­take home stud­ies mon­i­tor­ing sleep pat­terns. This in­volves neu­ro­log­i­cal leads from a portable de­vice be­ing at­tached to the scalp, with the per­son go­ing to sleep as nor­mal and the ap­pa­ra­tus col­lat­ing re­sults.

Mr Af­sar said the sleep study could be bulk-billed. For in­for­ma­tion, phone 9528 7755 or go to phar­macy777.com.au.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.